137 related articles for article (PubMed ID: 5032153)
1. Hepatotoxicity in rifampin-isoniazid treated patients related to their rate of isoniazid inactivation.
Smith J; Tyrell WF; Gow A; Allan GW; Lees AW
Chest; 1972 Jun; 61(6):587-8. PubMed ID: 5032153
[No Abstract] [Full Text] [Related]
2. Rifampin plus isoniazid in initial therapy of pulmonary tuberculosis and rifampin and ethambutol in retreatment cases.
Lees AW; Allan GW; Smith J; Tyrell WF; Fallon RJ
Chest; 1972 Jun; 61(6):579-82. PubMed ID: 4260668
[No Abstract] [Full Text] [Related]
3. The Australian rifampicin trial.
Proust AJ
Med J Aust; 1971 Jul; 2(2):85-94. PubMed ID: 4999365
[No Abstract] [Full Text] [Related]
4. Isoniazid plus rifampicin in the initial treatment of pulmonary tuberculosis.
Clarke GB; Cuthbert J; Cuthbert RJ; Lees AW
Br J Dis Chest; 1972 Oct; 66(4):268-71. PubMed ID: 5083434
[No Abstract] [Full Text] [Related]
5. Intermittent therapy with rifampin once a week in advanced pulmonary tuberculosis.
Verbist L; Mbete S; Van Landuyt H; Darras T; Gyselen A
Chest; 1972 Jun; 61(6):555-63. PubMed ID: 4624278
[No Abstract] [Full Text] [Related]
6. Rifampin and isoniazid in previously untreated patients with pulmonary tuberculosis.
Lees AW; Allan GW; Smith J; Tyrrell WF; Fallon RJ
Am Rev Respir Dis; 1972 Jan; 105(1):132-4. PubMed ID: 5007611
[No Abstract] [Full Text] [Related]
7. Side effects of rifampicin. A clinical study.
Mattson K
Scand J Respir Dis Suppl; 1973; 82():1-52. PubMed ID: 4518740
[No Abstract] [Full Text] [Related]
8. Toxicity form rifampicin plus isoniazid and rifampicin plus ethambutol therapy.
Lees AW; Allan GW; Smith J; Tyrrell WF; Fallon RJ
Tubercle; 1971 Sep; 52(3):182-90. PubMed ID: 4255439
[No Abstract] [Full Text] [Related]
9. Hepatotoxicity of rifampicin and isoniazid in children treated for tuberculosis.
Linna O; Uhari M
Eur J Pediatr; 1980 Sep; 134(3):227-9. PubMed ID: 6968680
[TBL] [Abstract][Full Text] [Related]
10. [Use of a isoniozid-rifompicin drug hepatotoxicity screening technic in tuberculosis therapy].
Viteau JM; Toulet J; Plonteux G; Abiven M; Bonfante N
Sem Hop; 1974 Jun; 50(28):1953-9. PubMed ID: 4374748
[No Abstract] [Full Text] [Related]
11. Hepatotoxicity from isoniazid and rifampin among children treated for tuberculosis.
O'Brien RJ; Long MW; Cross FS; Lyle MA; Snider DE
Pediatrics; 1983 Oct; 72(4):491-9. PubMed ID: 6604257
[TBL] [Abstract][Full Text] [Related]
12. [Synergistic effect of rifampicin on hepatotoxicity of isoniazid].
Skakun NP; Shman'ko VV
Antibiot Med Biotekhnol; 1985 Mar; 30(3):185-9. PubMed ID: 4015060
[TBL] [Abstract][Full Text] [Related]
13. Effects of two pulmonary tuberculosis drug treatments and acetylator status on liver function in a Zimbabwean population.
Neill P; Pringle D; Mhonda M; Kusema T; Nhachi CF
Cent Afr J Med; 1990 Apr; 36(4):104-7. PubMed ID: 2225025
[TBL] [Abstract][Full Text] [Related]
14. Rifampin-isoniazid compared with streptomycin-isoniazid in the original treatment of infectious pulmonary tuberculosis. Results of a controlled study.
Favez G; Chioléro R; Willa C
Chest; 1972 Jun; 61(6):583-6. PubMed ID: 4624280
[No Abstract] [Full Text] [Related]
15. [Role of isoniazid in hepatotoxicity with the INH-rifampicin combination in tuberculosis in children].
Dieu MJ
J Med Lyon; 1972 Oct; 53(234):1323-4 passim. PubMed ID: 4539047
[No Abstract] [Full Text] [Related]
16. Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis.
Grönhagen-Riska C; Hellstrom PE; Fröseth B
Am Rev Respir Dis; 1978 Sep; 118(3):461-6. PubMed ID: 707874
[TBL] [Abstract][Full Text] [Related]
17. Hepatotoxicity of rifampicin and isoniazid in children.
Casteels-Van Daele M; Igodt-Ameye L; Corbeel L; Eeckels R
J Pediatr; 1975 May; 86(5):739-41. PubMed ID: 1079531
[No Abstract] [Full Text] [Related]
18. Jaundice associated with rifampicin.
Hollins PJ; Simmons AV
Tubercle; 1970 Sep; 51(3):328-32. PubMed ID: 5495656
[No Abstract] [Full Text] [Related]
19. [Hepatotoxicity of the combination of isoniazid-rifampicin in African children. Role of malnutrition and HB virus].
Gendrel D; Nardou M; Mouba JF; Gahouma D; Moussavou A; Boguikouma JB
Arch Fr Pediatr; 1989 Nov; 46(9):645-8. PubMed ID: 2604523
[TBL] [Abstract][Full Text] [Related]
20. Human PXR modulates hepatotoxicity associated with rifampicin and isoniazid co-therapy.
Li F; Lu J; Cheng J; Wang L; Matsubara T; Csanaky IL; Klaassen CD; Gonzalez FJ; Ma X
Nat Med; 2013 Apr; 19(4):418-20. PubMed ID: 23475203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
